Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 8, 2025
Product Development

VEGF multispecifics get innovative at AACR 2025

New binding domains, target combinations and molecule structures define the VEGF multispecifics to be presented at AACR 2025
BioCentury | Apr 2, 2025
Product Development

VEGF bispecifics make inroads in other cancers, and more: Clinical Report

Plus: The week’s gainers and decliners after data
BioCentury | Apr 1, 2025
Distillery Therapeutics

Newly discovered myokine feimin for diabetes

BioCentury | Mar 4, 2025
Data Byte

Bispecifics overtake ADCs in China deals

Western biopharmas signed more deals for bispecifics than ADCs with China biotechs last year
BioCentury | Feb 25, 2025
Deals

Counteroffer from Tang-backed Concentra could scuttle Acelyrin-Alumis: Deals Report

Plus Radiance gets ROR1 ADC from Cspc, Astrazeneca buys Fibrogen’s China subsidiary and more
BioCentury | Feb 18, 2025
Product Development

Remaking Roche

How the once-dominant cancer company has overhauled its strategy for long-term growth
BioCentury | Feb 5, 2025
Product Development

Biotechs make inroads to precision medicine, solving long-standing problems

70% of new precision medicines approved by FDA in past three years were not sponsored by major pharmas
BioCentury | Jan 24, 2025
Finance

Ascentage lists on NASDAQ as Odyssey, Sionna, Aardvark plot IPOs

In BioCentury’s Finance Report, two more companies plan Hong Kong listings; Disc Medicine, Arctic raise cash
BioCentury | Jan 22, 2025
Product Development

Vir, Sana gain new modality POC: BioCentury’s Clinical Report

Plus readouts from Jasper, Dyne and more
Items per page:
1 - 10 of 1481